ZX-7101A

Phase 3Small molecule

NNanjing Zenshine Pharmaceuticals

ZX-7101A is one of 24 small molecule programs targeting Influenza. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

InfluenzaActive, not recruiting

InfluenzaPhase 3

Active, not recruiting

Competition

Competitive Landscape

1053 competitors in Influenza

#DrugCompanyPhaseTrials

Fluzone

Sanofi

Preclinical

16 2

ZX-7101A

NNanjing Zenshine Pharmaceuticals

Phase 3

4 3

Fluzone

GSK

Preclinical

37 4

Trexall

Alnylam Pharmaceuticals

Preclinical

1 5

Crestor

AstraZeneca

Preclinical

1 6

Avigan

AAppili Therapeutics Inc.

Preclinical

6 7

Quadrivalent Influenza Vaccine

Sanofi

Preclinical

30 8

COMIRNATY

Pfizer

Preclinical

1 9

Antihistamine

Arrowhead Pharmaceuticals

Preclinical

1 10

Focetria

CChiltern Pesquisa Clinica Ltda

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Influenza4 trials

Study to Assess the Safety and Efficacy of ZX-7101A for Oral Suspension in Chinese Pediatric Participants 2 to 11 Years of Age With Influenza

Recruiting·NNanjing Zenshine Pharmaceuticals·Phase 3·NCT07095257·168 enrolled

Study to Assess the Safety and Efficacy of ZX-7101A in Adolescents With Influenza

Completed·NNanjing Zenshine Pharmaceuticals·Phase 3·NCT06099873·361 enrolled

Study to Assess the Safety and Efficacy of ZX-7101A in Children Aged 5-11 Years With Influenza

Terminated·NNanjing Zenshine Pharmaceuticals·Phase 3·NCT06669351·98 enrolled

Show 1 more trial

A Study to Evaluate the Efficacy and Safety of ZX-7101A Tablets in Adults with Uncomplicated Influenza

Completed·NNanjing Zenshine Pharmaceuticals·Phase 2/3·NCT05702489·900 enrolled

Adult2 trials

Study to Evaluate the Pharmacokinetics and Relative Bioavailability of Metabolites in Healthy Chinese Adult Males

Completed·NNanjing Zenshine Pharmaceuticals·Phase 1·NCT06841926·40 enrolled

Substance Balance Study of [14C]ZX-7101A in Healthy Adult Male Subjects in China

Completed·NNanjing Zenshine Pharmaceuticals·Phase 1·NCT05720091·6 enrolled

Adult Subject2 trials

A Study to Assess the Effect of Itraconazole Capsules on the Pharmacokinetics of ZX-7101A Tablets in Healthy Adult Subjects in China

Completed·NNanjing Zenshine Pharmaceuticals·Phase 1·NCT05949385·16 enrolled

A Study to Evaluate Drug-drug Interaction of ZX-7101A Tablets and Oseltamivir Phosphate Capsules in Healthy Adult Subjects

Completed·NNanjing Zenshine Pharmaceuticals·Phase 1·NCT06057103·18 enrolled

Oral1 trial

A Study to Evaluate the Effect of a Single Oral Dose of ZX-7101A on the QTc Interval in Healthy Subjects

Completed·NNanjing Zenshine Pharmaceuticals·Phase 1·NCT05955027·24 enrolled

Tics1 trial

Study to Assess the Safety, Tolerability and Pharmacokinetics of ZX-7101A and the Food Effect in Healthy Volunteers

Completed·NNanjing Zenshine Pharmaceuticals·Phase 1·NCT05217732·66 enrolled

1 more indication

Hepatic Insufficiency1 trial

Pharmacokinetic Characteristics of Subjects with Hepatic Insufficiency and Healthy Subjects

Completed·NNanjing Zenshine Pharmaceuticals·Phase 1·NCT05711797·16 enrolled

Sources

References

[1]
ClinicalTrials.gov — 11 trial records for ZX-7101A. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — ZX-7101A compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for ZX-7101A. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Nanjing Zenshine Pharmaceuticals company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: NNanjing Zenshine Pharmaceuticals

ZX-7101A

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Influenza4 trials

Adult2 trials

Adult Subject2 trials

Oral1 trial

Tics1 trial

Hepatic Insufficiency1 trial

References

Drug Info

Quick Facts

Related News